|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2004-12-22
|
|
pubmed:abstractText |
The purpose of this study was to determine the safety and efficacy of nedaplatin and paclitaxel when given concurrently with radiation therapy (RT) for locally advanced non-small-cell lung cancer (NSCLC).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0368-2811
|
|
pubmed:author |
pubmed-author:AbeYoshinaoY,
pubmed-author:AokiMasahikoM,
pubmed-author:BasakiKiyoshiK,
pubmed-author:HasegawaYukihiroY,
pubmed-author:KondoHidehiroH,
pubmed-author:OkuderaKoichiK,
pubmed-author:OkumuraKenK,
pubmed-author:TakahataTakenoriT,
pubmed-author:TakanashiShingoS,
pubmed-author:TateishiTomonoriT,
pubmed-author:Yasui-FurukoriNorioN
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
34
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
647-53
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:15613553-Adult,
pubmed-meshheading:15613553-Aged,
pubmed-meshheading:15613553-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:15613553-Area Under Curve,
pubmed-meshheading:15613553-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:15613553-Combined Modality Therapy,
pubmed-meshheading:15613553-Drug Administration Schedule,
pubmed-meshheading:15613553-Female,
pubmed-meshheading:15613553-Humans,
pubmed-meshheading:15613553-Lung,
pubmed-meshheading:15613553-Lung Neoplasms,
pubmed-meshheading:15613553-Male,
pubmed-meshheading:15613553-Middle Aged,
pubmed-meshheading:15613553-Organoplatinum Compounds,
pubmed-meshheading:15613553-Paclitaxel,
pubmed-meshheading:15613553-Radiotherapy Dosage,
pubmed-meshheading:15613553-Survival Rate
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Weekly paclitaxel and nedaplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer: a phase I/II study.
|
|
pubmed:affiliation |
Second Department of Internal Medicine, Hirosaki University School of Medicine, 5 Zaifu-cho, Hirosaki 036-8562, Japan. yukihase@cc.hirosaki-u.ac.jp
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Clinical Trial, Phase II,
Clinical Trial, Phase I
|
